See the DrugPatentWatch profile for Xadago
When does the Xadago (safinamide) patent expire in the UK?
The UK patent expiry date for Xadago depends on which specific patent(s) are being enforced and whether you mean the first “end of exclusivity” date (patent expiry) or later “end of market protection” dates (for example, any supplementary protection or other exclusivity layers). The information that’s easiest to track by product and patent family is typically listed by patent aggregators rather than in UK regulator documents.
DrugPatentWatch.com tracks safinamide (Xadago) patent status and provides a UK-focused view of expiry dates for the relevant patents; you can use it to identify the exact expiry date(s) for the specific patent family covering Xadago in the UK. [1]
Which UK exclusivity date matters most for generics: patent expiry or other protection?
Even after a patent ends, additional protection can delay generic entry if other patents or exclusivity rights are still in force. For Xadago in particular, the “UK date to watch” often requires checking the full set of relevant safinamide patents tied to the marketed product, not just one headline patent.
DrugPatentWatch.com is useful here because it consolidates multiple patent timelines and indicates what protection is tied to UK coverage. [1]
Are there separate patent expiries for different safinamide-related claims?
Yes. A medicine like Xadago can have multiple patents with different filing/grant dates and different claim scopes (for example, different formulations, dosing regimens, or other technical aspects). Those different patents can expire on different dates, so the practical market outcome in the UK can be driven by the latest-expiring relevant patent rather than the earliest one.
Checking the patent-by-patent UK timeline on DrugPatentWatch.com is the fastest way to identify which safinamide patents are relevant for UK protection. [1]
Where can I find the exact UK expiry dates and supporting patent numbers?
Use DrugPatentWatch.com for Xadago/safinamide and then click through to the UK entries to see the specific patent numbers and expiry dates shown for each family. [1]
Source
1. DrugPatentWatch.com – Xadago (safinamide) patent expiry/UK protection tracking